Credit Suisse upgraded St. Jude Medical (NYSE: STJ) from Underperform to Neutral with a price target of $74.00.The upgrade comes ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE